AR Splice Variants in Circulating Tumor Cells of Patients With Castration‐resistant Prostate Cancer: Relation With Outcome to Cabazitaxel

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Circulating Tumor Cell Analysis in Patients With Progressive Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Circulating Tumor Cells in Patients With Castration-Resistant Prostate Cancer Baseline Values and Correlation With Prognostic Factors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Prolonged Therapy With Cabazitaxel in an Octogenarian With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2014English

The Cistrome and Gene Signature of Androgen Receptor Splice Variants in Castration Resistant Prostate Cancer Cells

Journal of Urology
Urology
2015English

Isolation and Genomic Analysis of Circulating Tumor Cells From Castration Resistant Metastatic Prostate Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology
Urology
2011English

Clinical Concepts for Cabazitaxel in the Management of Metastatic Castration‐resistant Prostate Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy